# Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer

> **NCT01672892** · PHASE3 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 289 (actual)

## Conditions studied

- Cervical Cancer
- Endometrial Cancer
- Gastrointestinal Complications
- Perioperative/Postoperative Complications
- Radiation Toxicity
- Urinary Complications
- Urinary Tract Toxicity

## Interventions

- **RADIATION:** Standard radiation therapy
- **RADIATION:** intensity-modulated radiation therapy

## Key facts

- **NCT ID:** NCT01672892
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2015-12
- **Final completion:** 2022-05-20
- **Target enrollment:** 289 (ACTUAL)
- **Last updated:** 2022-06-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01672892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01672892, "Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01672892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*